Medical Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. CBD Wellness products are not intended to diagnose, treat, cure, or prevent any disease, including ALS. All research cited is preclinical or preliminary unless otherwise noted. Always consult a qualified neurologist or healthcare provider regarding ALS treatment and care.
Written by: CBD Wellness Education Team
Reviewed by: Dr. Matthew Scott, PhD & DHSc
Last reviewed: June 2026
Amyotrophic lateral sclerosis (ALS) — widely known as Lou Gehrig's disease — is one of the most devastating neurological diagnoses a person can receive. Progressive, fatal, and currently without a cure, ALS strips patients of motor function while leaving cognitive ability largely intact. Emerging preclinical research suggests cannabinoids may hold genuine therapeutic potential for ALS, both in delaying disease progression and managing its most debilitating symptoms.
For related research, see our articles on cannabis and Alzheimer's disease, cannabis and Autism spectrum disorder, and cannabis and chronic pain.
What Is ALS?
ALS is a fatal neurodegenerative disorder characterized by progressive loss of motor neurons in the spinal cord, brain stem, and motor cortex. Key facts:
- An estimated 30,000 Americans are living with ALS at any given time
- Often arises spontaneously in otherwise healthy adults
- Average life expectancy post-diagnosis: three to five years
- No cure; approved medications offer only modest benefits
Common secondary symptoms include chronic pain, muscle spasticity, depression, appetite loss, and excessive drooling — often inadequately managed by existing pharmaceuticals.
Why Are Cannabinoids Being Studied for ALS?
The endocannabinoid system (ECS) plays a critical role in neuroprotection, neuroinflammation regulation, and motor neuron survival — all directly relevant to ALS pathology. CB1 and CB2 receptors are expressed throughout the motor cortex and spinal cord, the precise regions most affected by ALS. Learn more in our Beginner's Guide to CBD.
Key Research Findings
THC and Disease Progression: California Pacific Medical Center
Investigators at the California Pacific Medical Center in San Francisco reported in Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders that THC administered both before and after ALS symptom onset staved off disease progression and prolonged survival in animal models vs. untreated controls.
Cannabinoid Agonist AM-1241: University of Arkansas
Researchers at the University of Arkansas found that AM-1241 more than doubled survival rates in ALS animal models. Authors stated: "The magnitude of effect produced by AM-1241 initiated at symptom onset rivals the best yet reported for any pharmaceutical agent, even those given pre-symptomatic."
Plant-Derived Cannabis Extracts
A separate study using plant-derived cannabis extracts documented delayed ALS progression during early disease stages in a mouse model, suggesting whole-plant extracts — not just synthetic compounds — carry neuroprotective properties.
CBD and Disease-Modifying Potential
Most recently, scientists concluded that CBD may possess disease-modifying potential for ALS — meaning it may influence the underlying disease process, not just manage symptoms.
Symptom Relief: What Cannabinoids May Help With
- Chronic pain — see our full chronic pain research article
- Spasticity — well-documented in cannabinoid research
- Appetite loss — THC is well-known to stimulate appetite
- Depression and mood disturbance
- Sleep disruption
- Drooling (sialorrhea)
A Note for ALS Patients and Caregivers
CBD Wellness offers proprietary CBD tinctures, salves, and topicals — exclusively formulated in-house by our Chief Scientist, Dr. Matthew Scott, PhD & DHSc, with 15+ years of cannabinoid research. These formulas are not available anywhere else. All products are third-party lab tested. View our lab results here.
Contact us with any questions — we respond to every inquiry personally.
Continue Your CBD Education
- The Top 5 Health Benefits of Cannabis
- What Is CBD? A Beginner's Guide
- CBD vs THC — What's the Difference?
- Cannabis and Alzheimer's Disease
- Cannabis and Chronic Pain
- Cannabis and Epilepsy
- Cannabis and PTSD
Frequently Asked Questions: Cannabis and ALS
Can CBD help with ALS symptoms?
Preclinical research suggests cannabinoids may help manage ALS-related symptoms including chronic pain, spasticity, appetite loss, depression, and sleep disruption. CBD is not a cure for ALS. Always consult your neurologist.
Does THC slow ALS progression?
Preclinical studies from the California Pacific Medical Center found THC delayed disease progression and prolonged survival in ALS animal models. These findings have not yet been confirmed in large-scale human clinical trials.
Is CBD safe for ALS patients?
CBD is generally well-tolerated but can interact with medications metabolized by the liver's cytochrome P450 system. A physician should always be consulted before introducing CBD into an ALS patient's care plan.
Last Reviewed: June 11, 2026 — Reviewed by: Dr. Matthew Scott, PhD & DHSc, Chief Scientist, CBD Wellness — Next Review Scheduled: June 2027
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. CBD products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before starting any new supplement regimen.